As the Q4 earnings season comes to a close, it’s time to take stock of this quarter's best and worst performers in the data analytics industry, including Domo (NASDAQ:DOMO) and its peers.

Organizations generate a lot of data that is stored in silos, often in incompatible formats, making it slow and costly to extract actionable insights, which in turn drives demand for modern cloud-based data analysis platforms that can efficiently analyze the silo-ed data.

The 4 data analytics stocks we track reported a slower Q4; on average, revenues beat analyst consensus estimates by 0.9%. while next quarter's revenue guidance was 1% below consensus. Inflation (despite slowing) has investors prioritizing near-term cash flows, and while some of the data analytics stocks have fared somewhat better than others, they have not been spared, with share prices declining 8.7% on average since the previous earnings results.

Domo (NASDAQ:DOMO)

Founded by Josh James after selling his former business Omniture to Adobe, Domo (NASDAQ:DOMO) provides business intelligence software that allows managers to access and visualize critical business metrics in real-time, using their smartphones.

Domo reported revenues of $80.18 million, flat year on year, in line with analyst expectations. It was a decent quarter for the company, with EPS and operating cash flow topping analysts'estimates. Its revenue and RPO (remaining performance obligations) also slightly beat Wall Street's projections, and its EPS guidance for next quarter came in better than expected.

“The strategic investments we’re making this year will help customers capitalize on the new opportunities offered through artificial intelligence (AI) and data, making it easier and faster to scale Domo’s full suite of solutions across the entire organization,” said Josh James, founder and CEO, Domo.

Domo delivered the slowest revenue growth of the whole group. The stock is down 23.3% since the results and currently trades at $8.71.

Read our full report on Domo here, it's free.

Best Q4: Palantir (NYSE:PLTR)

Started by Peter Thiel after seeing US defence agencies struggle in the aftermath of the 2001 terrorist attacks, Palantir (NYSE:PLTR) offers software as a service platform that helps government agencies and large enterprises use data to make better decisions.

Palantir reported revenues of $608.4 million, up 19.6% year on year, in line with analyst expectations. It was a decent quarter for the company, with revenue and EPS exceeding expectations.

Palantir achieved the fastest revenue growth and highest full-year guidance raise among its peers. The stock is up 37.7% since the results and currently trades at $23.02.

Is now the time to buy Palantir? Access our full analysis of the earnings results here, it's free.

Weakest Q4: Health Catalyst (NASDAQ:HCAT)

Founded by healthcare professionals Tom Burton and Steve Barlow in 2008, Health Catalyst (NASDAQ:HCAT) provides data and analytics technology to healthcare organizations, enabling them to improve care and lower costs.

Health Catalyst reported revenues of $75.08 million, up 8.6% year on year, exceeding analyst expectations by 2%. It was a weak quarter for the company, with full-year revenue guidance missing analysts' expectations.

Health Catalyst delivered the biggest analyst estimates beat but had the weakest full-year guidance update in the group. The stock is down 21.7% since the results and currently trades at $6.63.

Read our full analysis of Health Catalyst's results here.

Amplitude (NASDAQ:AMPL)

Born out of a failed voice recognition startup by founder Spenser Skates, Amplitude (NASDAQ:AMPL) is data analytics software helping companies improve and optimize their digital products.

Amplitude reported revenues of $71.4 million, up 9.4% year on year, falling short of analyst expectations by 0.2%. It was a slower quarter for the company, with full-year revenue guidance missing analysts' expectations.

Amplitude had the weakest performance against analyst estimates among its peers. The company added 252 customers to reach a total of 2,723. The stock is down 27.5% since the results and currently trades at $10.2.

Read our full, actionable report on Amplitude here, it's free.

Join Paid Stock Investor Research

Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.